title: [The role of low molecular weight heparin (fragmin) in the prophylaxis and treatment of venous thromboembolism in major abdominal operations].
abstract: The goal of the authors was to prepare a thorough survey of the publications about the application of low molecular weight heparines in deep venous thromboses and pulmonary embolism after abdominal surgery. Several low molecular weight heparines have been introduced in clinical practice since 1980. Till then only standard heparin has been used for deep thromboses prevention. Both drugs have the same or similar anticoagulant or antithrombotic effect. Low molecular weight heparines are more widely used than standard heparin because of the possibility to be administered once daily subcutaneously. They don't require a strict laboratory control and can be used in outpatients or home conditions.
authors.forename: S
authors.initials: S
authors.lastname: Khinev
authors.forename: D
authors.initials: D
authors.lastname: Tsoneva
authors.forename: K
authors.initials: K
authors.lastname: Darfinova
authors.forename: B
authors.initials: B
authors.lastname: Kamenova
authors.forename: N
authors.initials: N
authors.lastname: Yar'mov
mesh_terms: D017985:Dalteparin / Q000627:therapeutic use*; D013505:Digestive System Surgical Procedures; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000517:prevention & control; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy / Q000517:prevention & control
chemical_list: D006495:Heparin, Low-Molecular-Weight; D017985:Dalteparin